Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 months
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2024.11.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Sonia Facchin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy; Gastroenterology Unit, Azienda Ospedale Università …. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Feces, Freezing, Clostridium Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Freezing donor fecal microbiota has improved fecal microbiota transplantation (FMT) for recurrent C. difficile infection (CDI), achieving short-term effectiveness similar to fresh-samples. Research shows frozen fecal matter remains effective for up to 12-months at -80 °C. OBJECTIVE: To assess how long-term-freezing and thawing affect the viability, microbial composition, and clinical efficacy of frozen-stools for FMT. METHODS: Stool samples from three donors were processed into 18 aliquots, thawed at intervals over two years, and analyzed for cell viability and microbial load. Microbiota composition was assessed through 16S-sequencing, with diversity evaluated using the Shannon-index and Principal-Coordinates-Analysis based on Bray-Curtis-distance (α/β-diversity). The same donors provided fecal material for a total of 23 FMT procedures, including 15 for CDI and 8 off-label. RESULTS: We found that donor stools frozen for two years contained viable bacteria comparable to fresh samples, with anaerobic and aerobic species remaining viable for 24 months. Despite a reduction in colony-forming-units, FMT was successful in 71.4 % and 100 % of the cases at one year and at the end of follow-up, respectively. Most bacterial changes occurred among anaerobic species (Blautia producta and Bifidobacterium adolescentis), increasing post-thawing. Notably, specific taxa, (C. aerofaciens and Erysipelotrichaceae_Cc115), showed significant unexplained increase. CONCLUSION: Long-term-stool-storage enhances FMT accessibility without compromising its success, despite taxonomic changes after 24 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy; Gastroenterology Unit, Azienda Ospedale Università di Padova, Padova, Italy.
- Research & Development Division, EuBiome S.r.l., 35131 Padova, Italy.
- Gastroenterology Unit, Azienda Ospedale Università di Padova, Padova, Italy.
- Microbiology Unit, Azienda Ospedale Università di Padova, Padova, Italy.
- Infectious and Tropical Diseases Unit, Padova University Hospital, Padua, Italy.
- Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy; Gastroenterology Unit, Azienda Ospedale Università di Padova, Padova, Italy. Electronic address: edoardo.savarino@unipd.i…
Zitieren
APA
Facchin, S., Cardin, R., Patuzzi, I., Carlotto, C., Minotto, M., Barberio, B., Zingone, F., Besutti, V. M., Castagliuolo, I., Cattelan, A., & Savarino, E. V. (2025). Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 months. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.11.025
Vancouver
Facchin S, Cardin R, Patuzzi I, Carlotto C, Minotto M, Barberio B, et al. Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 months. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.11.025
BibTeX
@article{Facchin2025,
author = {Facchin, Sonia and Cardin, Romilda and Patuzzi, Ilaria and Carlotto, Chiara and Minotto, Milena and Barberio, Brigida and Zingone, Fabiana and Besutti, Valeria M and Castagliuolo, Ignazio and Cattelan, Annanaria and Savarino, Edoardo V},
title = {Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 months},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.11.025}
}
EUVIMED